Results 31 to 40 of about 27,780 (214)

Emergence of carbapenem-resistant Enterobacteriaceae in Austria, 2001–2010 [PDF]

, 2011
We report the emergence of carbapenem-resistant Enterobacteriaceae in Austria. Over a 10-year period, carbapenem-resistant Enterobacteriaceae isolates were obtained from 13 hospitalized patients, with the first isolation in the year 2005 and a remarkable
Würstl, B., G. Zarfel, H.J.F. Salzer, Valentin, T., M. Hoenigl, R. Krause, Leitner, E., E. Leitner, T. Valentin, Hoenigl, M., J. Posch, Krause, R., Grisold, A.J., Zarfel, G., A.J. Grisold, Salzer, H.J.F., Posch, J., B. Würstl   +17 more
core   +1 more source

Emerging Carbapenem-Resistant Enterobacteriaceae Infection, Its Epidemiology and Novel Treatment Options: A Review

Infection and Drug Resistance, 2021
Mihret Tilahun, Yeshimebet kassa, Alemu Gedefie, Melaku Ashagire Department of Medical Laboratory Sciences, College of Medicine and Health Science, Wollo University, Dessie, EthiopiaCorrespondence: Mihret TilahunDepartment of Medical Laboratory Science ...
Tilahun M, kassa Y, Gedefie A, Ashagire M   +3 more
doaj  

Correlations of Antibiotic Use and Carbapenem Resistance in Enterobacteriaceae [PDF]

Antimicrobial Agents and Chemotherapy, 2013
ABSTRACT Epidemiological studies have shown a link between carbapenem use and resistance; however, the clinical relationship between antibiotic consumption and the epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae (CIRE) remains unclear.
Milena, McLaughlin, M Renee, Advincula, Michael, Malczynski, Chao, Qi, Maureen, Bolon, Marc H, Scheetz   +5 more
openaire   +2 more sources

First literature review of carbapenem-resistant Providencia

New Microbes and New Infections, 2018
Providencia species are Gram-negative bacteria that belong to the Enterobacteriaceae family. They have intrinsic resistance to colistin and tigecycline, which makes treatment of the multidrug-resistant strains of Providencia challenging.
M. Abdallah, A. Balshi
doaj   +1 more source

Prevalence of Carbapenem-Resistant Enterobacteriaceae and the Genes Responsible for Carbapenemase Production in a Tertiary Care Hospital in South India [PDF]

, 2023
Introduction: Carbapenem resistance in Gram-negative bacilli (GNB) is a major concern in the management of resistant infections. The mechanism of carbapenem resistance is most commonly mediated by carbapenemases. The five most common genes (NDM, KPC, VIM,
Archana Mahalingam, Bhaskar Shenoy, Devesh N. Joshi, Ranjeeta Adhikary, Shivkumar Shamarao, Bhavana MV   +5 more
core   +1 more source

Clinical Risk Factors and Microbiological and Intestinal Characteristics of Carbapenemase-Producing Enterobacteriaceae Colonization and Subsequent Infection

Microbiology Spectrum, 2022
Gastrointestinal colonization with carbapenem-resistant Enterobacteriaceae (CRE) is always a prerequisite for the development of translocated infections.
Wenli Yuan, Jiali Xu, Lin Guo, Yonghong Chen, Jinyi Gu, Huan Zhang, Chenghang Yang, Qiuping Yang, Shuwen Deng, Longlong Zhang, Qiongfang Deng, Zi Wang, Bin Ling, Deyao Deng   +13 more
doaj   +1 more source

Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae

New England Journal of Medicine, 2019
Plazomicin for Severe Resistant Infection This report compared plazomicin with colistin for the treatment of severe (bloodstream or pneumonia) infection with carbapenem-resistant Enterobacteriaceae...
McKinnell, J.A., Dwyer, J.P., Talbot, G.H., Connolly, L.E., Friedland, I., Smith, A., Jubb, A.M., Serio, A.W., Krause, K.M., Daikos, G.L.   +9 more
openaire   +3 more sources

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

Brazilian Journal of Infectious Diseases, 2017
This study evaluated the in vitro activity of ceftolozane-tazobactam and comparator agents tested against Latin American isolates of Enterobacteriaceae and Pseudomonas aeruginosa from patients with health care-associated infections.
Michael A. Pfaller, Dee Shortridge, Helio S. Sader, Ana Gales, Mariana Castanheira, Robert K. Flamm   +5 more
doaj   +1 more source

Detection of Klebsiella pneumoniae Carbapenemase (KPC) Producing Enterobacteriaceae Isolates from Various Clinical Samples in a Rural Health Setup

Journal of Pure and Applied Microbiology, 2020
Carbapenem resistance is increasing and emerging as a public health threat. The Indian subcontinent serves as a reservoir for all 3 types of carbapenemases: KPC, OXA-181 and NDM. The present study was done to determine the antibiotic resistance pattern
Arveen Sokhi, Priti Agarwal, Megha Maheshwari, Anita Chakravarti   +3 more
doaj   +1 more source

Activities of imipenem-relebactam combination against carbapenem-nonsusceptible Enterobacteriaceae in Taiwan

Journal of Microbiology, Immunology and Infection, 2022
Background: Imipenem-relebactam is a new β-lactam and β-lactamase inhibitor combination to treat carbapenem-resistant gram-negative bacteria infections. However, difference in carbapenem resistant mechanisms existed with geographic variations. Objective:
Tsung-Ying Yang, Ya-Ju Hsieh, Li-Ting Kao, Guan Hong Liu, Shao-Hsuan Lian, Liang-Chun Wang, I-Ling Lin, Hsian-Yu Wang, Sung-Pin Tseng, Po-Liang Lu   +9 more
doaj   +1 more source